Ives Bruce Alan purchased $30K of IIPR

Ives Bruce Alan purchased 528 shares of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) at $56.70 on 2026-08-31.

Original reporting
SEC EDGAR · Ives Bruce Alan
Published Sep 1, 2026, 8:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IIPR
Neutral
high confidence
Mentioned
$IIPR
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IIPRNeutralLow
01

Why it matters

The purchase is a routine insider transaction with limited market impact.

02

Market read

Minor relevance; primarily of interest to insiders and compliance monitors.

03

What to watch

If the director is accumulating ahead of a pending corporate action, the purchase could gain relevance later.

Relevance 4/10Novelty 3/10Timing: post-market

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$IIPRNeutralHigh confidence
Context

Director Ives Bruce Alan purchased 528 shares at $56.70 each, total $29,937.60, increasing his holding to 3,180 shares.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size is modest relative to the company's market cap and typical trading volume; director purchases are monitored but this amount is not material.

Market effects

None; REIT sector not affected by a single small insider buy.

None; transaction is US‑based and limited to one company.

None

Counterpoint

Even small insider buys can signal confidence; some traders may view it as a subtle bullish cue.

Key entities

  • Innovative Industrial Properties Inc

    US‑listed REIT focused on cannabis‑related real estate.

  • Ives Bruce Alan

    Director of IIPR who executed the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IIPRMedAI 8/10

Innovative Industrial Properties, Inc. and IIP Operating Partnership, LP entered into amendments to each of the Company's existing equity distribution…

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On November 9, 2026, Innovative Industrial Properties, Inc. (the “Company”) and IIP Operating Partnership, LP entered into amendments (collectively, the “Amendments”) to each of the Company's existing equity distribution agreements with BTIG, LLC, Piper Sa

$IIPRLow

Innovative Industrial Properties Inc (IIPR) (Q3 2026) Earnings Call Highlights: Record

Innovative Industrial Properties Inc (IIPR) reported Q3 2026 earnings, highlighting record leasing activity but also challenges. The company regained properties from tenants like Parallel and PharmaCann, facing a 6-18 month re-leasing timeline. Non-recurring rent recoveries boosted AFFO by $0.15 per share. IIPR has 800,000 sq ft of vacancy, mostly in Florida. Security deposits for four of five tenants are exhausted.

$IIPRHighAI 9/10

Innovative Industrial Properties Q3 Earnings Call Highlights

Innovative Industrial Properties (IIPR) reported Q3 earnings, highlighting $14.3M in interest and other income. The company committed $545M to life sciences, expecting 26% of annualized income. It funded $111M for Alewife Park, with a 15.8% average interest rate. Leasing activity reached a record 874,000 sq ft. IIPR raised $54M from a preferred stock offering and extended its credit facility. Management sees opportunities in life science assets and cannabis real estate.

$IIPRMed

Innovative Industrial (IIPR) Q3 2026 Earnings Call Transcript

Innovative Industrial (IIPR) reported Q3 2026 earnings with AFFO per share up 7% to $1.96. The company committed $545M to life science investments, expected to generate ~15.8% interest. It also completed a $54M preferred stock offering. Leasing activity totaled 1.3M square feet year-to-date. The company sees opportunities in life science and cannabis sectors, with federal cannabis reform potentially benefiting operators.